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Richard J Cooke2, Mark S Pearce3, Kieren G Hollingsworth6, Michael I Trenell6 and Nicholas D Embleton1,2,3*Abstract
Background: Preterm infants represent up to 10% of births worldwide and have an increased risk of adverse
metabolic outcomes in later life. Early life exposures are key factors in determining later health but current lifestyle
factors such as diet and physical activity are also extremely important and provide an opportunity for targeted
intervention.
Methods/Design: This current study, GROWMORE, is the fourth phase of the Newcastle Preterm Birth Growth
Study (PTBGS), which was formed from two randomised controlled trials of nutrition in early life in preterm
(24–34 weeks gestation) and low birthweight infants. 247 infants were recruited prior to hospital discharge. Infant
follow-up included detailed measures of growth, nutritional intake, morbidities and body composition (Dual X Ray
Absorptiometry, DXA) along with demographic data until 2 years corrected age. Developmental assessment was
performed at 18 months corrected age, and cognitive assessment at 9–10 years of age. Growth, body
composition (DXA), blood pressure and metabolic function (insulin resistance and lipid profile) were assessed at
9–13 years of age, and samples obtained for epigenetic analysis. In GROWMORE, we will follow up a representative cohort
using established techniques and novel metabolic biomarkers and correlate these with current lifestyle factors including
physical activity and dietary intake. We will assess auxology, body composition (BODPOD™), insulin resistance, daily
activity levels using Actigraph™ software and use 31P and 1H magnetic resonance spectroscopy to assess
mitochondrial function and intra-hepatic lipid content.
Discussion: The Newcastle PTBGS is a unique cohort of children born preterm in the late 1990’s. The major
strengths are the high level of detail of early nutritional and growth exposures, and the comprehensive
assessment over time. This study aims to examine the associations between early life exposures in preterm
infants and metabolic outcomes in adolescence, which represents an area of major translational importance.
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The Developmental Origins of Health and Disease hypo-
thesis suggest that nutritional imbalance during critical
windows in early life can permanently influence long-term
development and disease in later life [1]. Whilst the major-
ity of epidemiological and other studies relate to infants
born at term, there are increasing data, supported by con-
trolled longitudinal studies, to show that similar effects
occur in infants born preterm (<37 completed weeks gesta-
tion) [2]. Preterm births account for 5-10% of births in the
UK and almost 10% of all births worldwide, representing
more than 15 million births globally every year [3]. In de-
veloped countries, survival has dramatically improved in
the last few years. More than 50% of babies born at
24 weeks gestation are now regularly surviving long term
[4]. Despite these improvements, providing adequate nutri-
tion to preterm infants is challenging and growth failure is
common [5]. Most extremely preterm infants (<32 weeks
gestation) require support with parenteral nutrition,
metabolic ‘immaturity’ may limit nutrient intake, and
enteral feeds take time to establish. Expressed breast
milk is associated with a range of benefits in the short-
term (e.g. reduction in the incidence of necrotising en-
terocolitis [6], a potentially fatal illness associated with
milk feeds) and long-term (e.g. improved cognitive
outcome), but alone will not meet nutrient require-
ments without fortification [7].
Because of these nutritional and other challenges, pre-
term infants accumulate nutrient deficits during hospital
stay and most are discharged with weights below the 10th
centile. Many preterm infants demonstrate catch up in
weight after hospital discharge, a time period equivalent
to that in term born infants known to be strongly associ-
ated with later metabolic risk [8]. Children and adults
born preterm demonstrate important differences in many
aspects of their biology: cognitive outcome is worse [4],
blood pressure is higher [9] and there is an increased
prevalence of type II diabetes [10]. Other aspects remain
less certain, for example data regarding the timing and
progression of puberty after preterm birth are still con-
flicting [11,12]. Randomised controlled trials (RCTs) have
shown that growth and nutrient intakes in early life in pre-
term infants affect metabolic outcomes in later childhood
such as abnormal fat deposition, insulin sensitivity and
vascular health [13-15]. Studies also show that early nutri-
tion affects later cognitive outcome [16,17]. However,
there are few longitudinal cohorts of preterm infants and
there remain major uncertainties about how best to feed
preterm infants. The risks and benefits of rapid growth
promotion in both the pre- and post-discharge period,
and in later childhood remain to be determined [18].
Along with accumulating evidence that early life expo-
sures are key factors in determining later health, current
lifestyle factors such as diet and physical exercise arealso extremely important and provide an opportunity for
targeted intervention. Recent efforts to improve nutri-
tional status in adolescent children have proven difficult,
and many of the factors that require change (e.g. diet,
mealtimes, physical activity etc.) exist in a complex
socio-cultural environment. In addition, although there
is some evidence that short-term outcomes such as BMI
(or fat mass index) can be modified, there are few data
showing that insulin resistance or other markers of the
metabolic syndrome are modifiable in children [19].
Determining the role of early life events in modulating
the later risk of type 2 diabetes, obesity or hypertension
require long term study as the underlying abnormal
metabolic processes take decades before manifesting as
disease. There are many challenges for longitudinal co-
hort studies, especially in high-risk cohorts such as chil-
dren born preterm, including attritional losses over time
[20] and changes in health care interventions that might
limit generalizability to contemporary practice. Despite
the enormous wealth of literature pertaining to animals,
there are few prospective cohort studies in humans with
detailed phenotypic characterization. Examples include
the Avon Longitudinal Study of Parents and Children
[21] and the Gateshead Millenium Study [22]. In some
cohorts, follow up rates remain an issue, and most have
only been tracked into childhood. Large-scale epidemio-
logic studies have provided a wealth of information on
early growth patterns and long-term outcomes [23,24]
but phenotypic characterisation of infant and childhood
events are largely restricted to auxological parameters
(i.e. weight, height and body mass index (BMI)) and
there are few data with direct assessment of body com-
position. Whilst detailed phenotypic characterisation is
present in certain longitudinal studies, most lack the
granularity of information around delivery and in early
postnatal life. Most regular birth cohorts also have pre-
term births under-represented, as difficult births are more
likely to be omitted from sample collection due to other
clinical priorities. Most adult cohorts are unable to deter-
mine relative differences in lean or fat mass accretion in
early childhood, and data on early nutrient intake is largely
limited to population estimates [25,26].
Much of the current data available from preterm in-
fants is in cohorts recruited to studies in the 1980’s, an
era pre-dating the widespread use of antenatal steroids
and surfactant therapy. These two key perinatal practices
have had dramatic effects on morbidity and mortality,
and will have major effects on later outcomes. The
Newcastle Preterm Birth Growth Study (Newcastle
PTBGS) is a unique cohort of children born preterm
in the late 1990’s. The major strengths are the detail
of early nutritional and growth exposures, and the com-
prehensive assessment over time that includes growth,
metabolic, neuro-cognitive, and body composition
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comes from an RCT perspective, thereby avoiding some
of the challenges of reverse causation and confounding.
Birthweight is a relatively crude measure of fat or lean
mass, but despite this a clear relationship exists between
birthweight and later lean mass and muscle strength
[27,28]. This appears to be independent of muscle mass,
suggesting that fetal and possibly infant growth perman-
ently alter cellular function [29]. Intramyocellular and
intrahepatic lipid accumulation alongside abdominal lipid
depots compromise the ability to oxidise lipid, demon-
strated by reduced muscle mitochondrial capacity and
whole body cardiorespiratory fitness, both of which are
key determinants of insulin sensitivity. Physical activity
and inactivity are also important environmental modu-
lators of insulin sensitivity through their direct and in-
direct influence on insulin action and also their role in
weight maintenance. This strongly suggests that a
comprehensive approach to outcome measurement in
intervention trials is needed rather than focusing sim-
ply on weight loss or change in BMI. There are limited
data on regional lipid deposition, oxidative capacity
and glucose control across childhood, especially in
those with detailed information of early growth and
nutrient exposure.
To examine the relative importance of early growth and
nutritional factors, and how these might confound or inter-
act with later childhood factors requires study in cohorts
with detailed phenotypic data. Genetic and/or epigenetic
characterisation is likely to further improve understanding
including possible mediating mechanisms (including mo-
lecular factors such as epigenetic processes) and establish-
ing the direction of causality. In addition, there is a need to
determine whether robust markers of later risk for type 2
diabetes, such as childhood insulin resistance (measured
with fasting insulin and glucose and/or using an oral glu-
cose tolerance test (OGTT), or intrahepatic/intramyocellu-
lar accumulation are modifiable. To do this, there is a need
to first determine the current range of these parameters in
high-risk groups and examine relationships with current
measures of diet, physical activity and cardiorespiratory
fitness, and establish the types of interventions that
might be effective in decreasing the risk.
The aim of this study is to examine the associations be-
tween early life exposures in preterm infants and later
metabolic outcomes and their mediators. We will follow
up a cohort of preterm infants from the Newcastle PTBGS
as teenagers to determine the presence of novel metabolic
biomarkers and correlate these with lifestyle factors.
Methods
Study setting
The current study is embedded within the Newcastle
PTBGS, which is a prospective cohort study based ontwo RCTs of varying nutrient intake in preterm infants:
one study where the intervention was in the post-discharge
period (standard versus nutrient enriched formula), and
the second spanning the pre- and post-discharge period
where differing protein, but iso-caloric formula intake
densities, were fed [30,31]. All participants were born and
recruited between 1993 and 1998 from a single tertiary
neonatal centre, the Special Care Baby Unit at the Royal
Victoria Infirmary in Newcastle upon Tyne. A control
group of infants who were primarily breast-fed on hospital
discharge, and some co-twins supplemented the two inter-
ventional cohorts. The infants of both RCTs and controls
were combined to form the Newcastle PTBGS cohort.
The RCTs aimed to recruit infants who were born
≤34 weeks gestation and had a birthweight of ≤1750 g.
In the first RCT, referred to as the ‘growth study’, infants
were randomised to one of two formulae on discharge
from hospital. They were either fed (A) a preterm infant
formula from discharge to 6 months post-term, (B) a
standard term formula from discharge to 6 months or (C)
the preterm formula from discharge to term and then the
standard term formula until 6 months (‘crossover’ group).
Preterm formula had an energy density of 80 kcal and
2.2 g protein, and term formula was 67 kcal and 1.6 g pro-
tein per 100 mL [32]. Further details of the nutrient com-
position of the formula are provided elsewhere [32]. A
control group of breastfed babies was also included. In-
fants were seen at the outpatient clinic fortnightly between
discharge and term and monthly between term and
6 months corrected age. At each clinic visit, milk intake,
auxology (length, weight, mid-arm circumference, MAC,
occipito-frontal head circumference, OFC) and serum bio-
chemistries were determined. Formula milk intake was de-
termined by providing pre-weighed ready to feed formula,
and re-weighing used bottles. Body composition was
assessed at different time points including hospital dis-
charge, term, 12 weeks, 6 months, and 12 months using
dual energy x-ray absorptiometry (DXA) scans. Auxologi-
cal measures were repeated at 18 and 24 months. Bayley
Scales of Infant Development (BSID) mental development
index (MDI) and psychomotor development index (PDI)
tests were assessed at 18 months [30].
In the second RCT, the ‘protein study’, 77 infants were
randomised to one of three preterm formulas that were
iso-caloric (80 kcal/100 mL), but differed in protein density
(A - 3.3 g, B - 3.0 g, and C - 2.7 g per 100 kcal) [31]. Infants
were recruited once full enteral feeding had been success-
fully established and they continued on the trial formula
post-discharge until 12 weeks post-term. Milk intake,
auxology and serum biochemistries were determined weekly
during inpatient stay, and every 4 weeks until 12 weeks.
Auxology was repeated 6 monthly until 24 months. Body
composition was assessed using DXA at discharge
and at 12 weeks.
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pects of family structure, parental employment, educa-
tion history, smoking etc., was completed prior to
hospital discharge. Although the inclusion criteria for
randomisation into the two RCTs was a gestational age
of ≤34 weeks, 1 set of low birthweight triplets of
36 weeks gestation were included as breastfeeding con-
trols, along with siblings of eligible infants whose birth-
weight was >1750 g. Because of a small time overlap in
the recruitment period for the two RCTs (randomised
infants could only join one RCT) there were 4 breast fed
control infants who were initially included in study re-
ports for both studies, but thereafter are only included
once in the combined cohort. Mean gestation for the co-
hort (n = 247) was 30.9 weeks (range 24.7-36.4 weeks)
and birthweight 1392 g (range 690-2200 g). One hun-
dred and twenty five were male. There were no signifi-
cant differences in gestation or weight between boys
and girls.
The Newcastle PTBGS has previously been followed up
on three occasions since the initial randomised controlled
trials (see Table 1). The current study, GROWMORE,
will be phase four of follow-up [33].
GROWMORE study protocol
Hypotheses
1. Muscle oxidative capacity determined by 31P MRS
and cardiorespiratory fitness are related to measures
of physical activity, physical inactivity, insulin
resistance and Vitamin D status in adolescence.
2. Auxological measures (weight, height, OFC and
skinfold) provide a reliable measure of adiposity
compared to non-invasive body composition
assessment using air displacement plethysmography
(BODPOD™).
3. Intra-hepatic or intra-myocellular lipid accumulation
is related to markers of insulin resistance, raised
triacylglycerol and measured body fat in adolescents
4. Body composition and metabolic outcomes in
adolescence are related to patterns of infant growth,
body composition and nutritional intakes.
Power calculation
Determining an appropriate sample size for this study is
difficult given there are multiple outcome variables,
including some exploratory, being investigated. Using
results from phase three of this study, we know that in-
sulin sensitivity is strongly associated with fat mass
index. Using the effect size from our data of r2 = 0.12,
with 80% power at the 5% level of significance we esti-
mated that we would need ~60 patients to be able to detect
a significant difference. Previous work looking at mito-
chondrial oxidative function in the Magnetic Resonancecentre required a sample size of only 10 patients to deter-
mine a 10% reduction in τ1/2 PCr [34]. Therefore we have
chosen to study 60 young people, as this will ensure an
adequate sample size for two of the main outcome variables.
Current study population and recruitment
All children who participated in phase 3 (n = 153) will
be approached, via mail, after verifying postal address
through their general practitioner. We will approach the
young people sequentially starting with the oldest, but
no other active selection process will be used. A recruit-
ment letter, explaining the study and assessments in de-
tail will be sent to all parents whose children fit the
above criteria and a simplified patient information sheet
sent to the young person. Informed, written consent will
be obtained from parents and where appropriate, parti-
cipants, before participation.
Study design
The same researcher (RT) will carry out all assessments.
Figure 1 shows the study protocol flowchart. All initial as-
sessments will be carried out during a single morning visit
to the Newcastle Magnetic Resonance Imaging Centre.
Participants will attend fasted. Once the initial assessment
is finished (within 4 hours), the pre-programmed accele-
rometers (Actigraphs) will be given to each young person
to wear for 3 days and a feedback questionnaire given.
The Actigraph and questionnaires will then be returned
and data analysed.
We will use the following methods during assessment:
1. Anthropometry
 Height will be measured to the nearest 0.1 cm,
using a telescopic stadiometer (SECA,
Birmingham, UK)
 Weight will be taken to the nearest 0.1 kg from
the BODPOD™ (Cosmed, USA). BMI will be
calculated using these measurements. Standard
deviation scores will be calculated for height,
weight and BMI using standard reference data.
 Waist circumference will be measured using a
measuring tape (CTO Group, China).
 Weight and height standard deviation scores,
adjusted for sex and age will be calculated using
the LMS calculator and British 1990 growth
reference standards [35,36].
 Blood pressure will be taken from the right arm,
using an automated sphygmomanometer.
(Carescape vital signs monitor, GE Healthcare
systems, UK)
2. Body composition
Initially, Holtain calipers (Crymych, UK) will be
used to measure skinfold thickness in four
areas- biceps, triceps, subscapular and suprailiac.
Table 1 Data collected during follow-up phases of the Newcastle preterm birth growth study
Phase 1- Growth and Protein study RCTs Phase 2- Cognitive/Behavioural follow-up
at 10 years
Phase 3- Early adolescent follow-up Phase 4- Late adolescent follow-up
(n = 247) (n = 92 from 113 in growth study) (n = 153 from 247 in RCTs) (n = 60 from 153 in phase 3)
Auxology: Auxology: Auxology:
Length*, weight, OFC at birth, discharge, term,
1,2,3,6,12,18,24 months corrected age
Wechsler Intelligence Scale for Children version
3 (WISC III) including Wechsler Objective Numerical
Dimensions (WOND), Wechsler Objective Reading
Dimensions (WORD) and Wechsler Objective
Language Dimensions (WOLD). Achenbach Child
Behaviour Checklist. Vineland adaptive behavior
scales (n = 113)
Height, weight, OFC, abdominal
circumference, waist/hip ratio
Height, weight, waist circumference, blood
pressure. Self assessment of pubertal status
Blood pressure
Self-assessment of pubertal
status
(n = 153)
Bloods: Bloods: Bloods:
Serum Biochemistry weekly till term then 1,2,3 months Short oral glucose tolerance test 2 hour glucose tolerance test, 25-OHD,
lipid profile, liver function, sex hormones,
RNA, cellular DNA and serum to storeFasting Lipids: cholesterol, triglycerides
Leptin, adiponectin, insulin and IGF1 (n = 70 subset) Leptin, adiponectin
(n = 109)
Body composition: Body composition: Body composition:
DXA at discharge and/or term, 3,6,12 months (6 and
12 months only growth study)
DXA scan and bio-impedance BODPOD
(n = 139) IHL and IMCL deposition using 1H magnetic
resonance spectroscopy
Social questionnaire Socioeconomic deprivation score Social and family history SCRAN-24 dietary information
Actigraph data
Intervention and feedback questionnaires
BSID II MDI and PDI at 18 m (Growth study n = 113)
*Length not available pre-discharge for most.
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Figure 1 The study protocol flowchart.
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density [37,38]. A second estimate of body
composition will also be made using BODPOD™
[39,40]. The BODPOD uses air displacement
plethysmography and has been validated for use in
children [41]. BODPOD measures body mass and
volume by calculating differences in volume of the
participants compared to calibration volumes
(age-dependent) of the participant sitting inside
the BODPOD, thus allowing body density to
be calculated. Once overall body density is
determined, the relative proportions of lean and
fat body mass can be calculated.
3. Biochemistry and insulin sensitivity
All participants will attend fasted. Baseline bloods
will be taken (for lipid profile, liver function,
glucose, insulin, sex hormones, RNA, cellular
DNA and serum to store) and then a standardised
fasting-state oral glucose tolerance test will be
performed [42]. Insulin sensitivity and resistance
will be measured using the Homeostasis Model
Assessment (HOMA) method.
Sinha et al. [34] have also demonstrated a
clear association between skeletal muscle
mitochondrial oxidative function and serum
vitamin D levels in patients with Growth
Hormone deficiency using the same 31-P MRS
exercise protocol as we will use. In order to ensure
we can control our data for any influence of
vitamin D status, frozen serum will be assayed
using a Liquid Chromatography-Tandem Mass
Spectrometry (LC-MS/MS) method to obtain a
25-OH Vitamin D quantification.4. Epigenetic sampling
We will seek consent to store any spare serum and
DNA (extracted from blood and saliva) for future
analysis [43,44]. These samples will be subject to
the Human Tissue Act 2004 [45] and held under
license (issue number 12534, held by Newcastle
Biomedicine Biobank). DNA will be extracted at
the Institute of Genetic Medicine, Newcastle
University, Newcastle-upon –Tyne using standard
techniques [46-48].
5. Measurement of intra-hepatic lipid
Intra-hepatic lipid (IHL) and Intra-myocellular
lipid (IMCL) deposition will be determined using
1H magnetic resonance spectroscopy. Details of
the planned MR sequences will be similar to those
used in our previous work [49]. Percentage of
intrahepatic lipid will be calculated using the % of
CH2 lipid peak signal amplitude, relative to the
water peak signal amplitude [50-52].
6. Measurement of mitochondrial oxidative function
We will use custom-built exercise apparatus to
allow each participant to perform a standardised
exercise protocol as previously described by
members of our group [34,53,54], consisting of
plantar flexion against fixed resistance during
which time 31 P-MRS will be used to assess
mitochondrial oxidative function (see Figure 2.
In order to generate the 31P spectra, a 10 cm
diameter 31P surface coil will be placed over the
calf muscles, centred on the widest part of the
gastrocnemius/soleus complex, for transmission
and reception of the signal. After calf muscle
group maximum voluntary contraction (MVC)
Figure 2 Typical 31-P spectra generated during exercise within
the MR scanner and the equipment that will be used for the
study [55].
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exercise apparatus will be set to provide resistance
of 35% of MVC, and 31P spectra will be recorded
over a three minute time window to assess resting
mitochondrial function. This will be immediately
followed by a three-minute exercise period during
which the participants will be required to perform
plantar flexion against the set resistance at a
frequency of 0.5 Hz and then a further rest period.
MR phosphorous spectra will be collected every
10 seconds during the protocol using adiabatic
One-Dimensional Image-Selected In-vivo
Spectroscopy (1D-ISIS). This protocol has been
shown to robustly measure mitochondrial oxidative
function during recovery from exercise [34,53].
The phosphorus spectra will be analysed in
batches using the Advanced Method for Accurate,
Robust and Efficient Spectral fitting (AMARES)
algorithm [56] and from this quantifications of
phosphocreatine (PCr), inorganic phosphate (Pi)
and pH throughout the protocol will be obtained.
The data will then be processed to calculate the
various components of oxidative metabolism as
described by Kemp and Radda [57]. The primary
outcome measure will be the half-time of PCr
recovery [53] (τ1/2 PCr). This recovery period is
used to measure mitochondrial oxidative
phosphorylation ‘capacity.’ In addition, the
half-time of ADP (τ1/2 ADP) recovery will be
measured as it provides a similar measure to τ1/2
PCr but may be more resistant to heterogenous
pH responses at the end of exercise.
7. Physical activity levels
Physical activity levels over a 24-hour period will
be measured using an Actigraph ™accelerometer
(Actigraph, Pensacola, FL). The Actigraph is a
small and lightweight monitor that will be worn
on the right hip during waking hours for three
days. The Actigraph has high validity, reliability,and low reactivity in children [58] and has been
used successfully in several paediatric physical
activity studies [59]. The accelerometers will be set
to record data in 10-second epochs. Analysis of the
activity data will be performed using Actilife
program (v5, MTI, Pensacola, USA). A written diary
will also be kept to monitor periods of non-wear.
From the data gained we will calculate the time
spent in sedentary or moderate to vigorous physical
activity (MVPA). MVPA has been chosen rather
than looking individually at different activity levels:
it has been shown in a term born group of children
in north east England that MVPA seems to be most
closely associated with body habitus change when
followed longitudinally [60].
8. Diet and nutritional assessment
The SCRAN-24 dietary recall program will be used
to determine each participant’s food/drink intake
over the previous 24 hours. (Human Nutrition
Research Centre, Newcastle University) [61].
SCRAN-24 uses a series of steps to determine the
times of food/drink intake over the 24 hours prior to
using the program. It asks the user to list
chronologically the items of food or drink
consumed in the 24-hour period under a series
of headings (breakfast, mid-morning snack, lunch
etc.). It then breaks down each intake into their
component parts. For the majority of foodstuffs
(98% of those regularly consumed by children in the
north east of England), the programme contains a
listed item. Non-listed items have to be entered in
free-text. Once the items are selected for the full
24-hour period the program then revisits each
episode of food intake and prompts the participant
to assess and log portion size based on a series of
photo-based choices. Pre-programmed nutritional
information for each listed item, by portion size is
allocated to each item. A final step prompts the user
to try to link food and drink intake with activity
through the day and highlights any times of the day
during which nothing was ingested as particular areas
to focus on. This is done to try to improve recall and
thus improve the sensitivity of the diary. SCRAN-24
has been validated for use in people in the north east
of England aged 11 years of age or over.
9. Questionnaires
Intervention questionnaires will also be given to
the participants, asking opinions on different
potential structured activities within a programme
designed to encourage a healthier lifestyle in
children and their families. This data will help to
inform potential future interventional studies
about which interventions might be most accepted
by a similar teenage cohort.
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son a feedback questionnaire to fill in to assess their ex-
perience of the study assessment day and their perceived
acceptability of the assessment methods. By reviewing
how many participants accept, decline or are unwilling/
unable to complete particular assessments we will gauge
their usefulness for future trials.
The study has been approved by the Sunderland
Research Ethics Committee and the Research and Devel-
opment Department of Newcastle Hospitals NHS Trust.
Statistical analysis
Data will be analysed using Stata (v11, StatCorp LP,
Texas, USA). Mann–Whitney U or t tests will be used
to demonstrate that the follow-up sample is broadly rep-
resentative of the original cohort for key variables such
as gestation and birth weight. Correlation analysis will
be used to examine the relationships between the diffe-
rent measures of body composition and the MR mea-
sures of lipid deposition and to examine the interaction
between vitamin D and oxidative capacity by 31P MRS
and cardiorespiratory fitness. To assess associations be-
tween infant and childhood growth and subsequent
metabolic outcomes, we will develop separate linear re-
gression analysis models using insulin sensitivity and body
composition (fat mass index and lean mass index) as the
dependent variables. Half-time of PCr recovery (τ1/2 PCr)
will be used as dependent variable for regression models
examining muscle mitochondrial function in relation to
insulin sensitivity, directly measured exercise, body com-
position and vitamin D levels (as independent variables).
In all multiple linear regression models adjustment will be
made for potential confounding factors such as sex, gesta-
tion, age at follow-up, birthweight z-score, infant growth
velocity, post discharge feeding pubertal status and
whether mechanical ventilation was required in the neo-
natal period (which we used as a proxy for illness severity).
Bland Altman analysis will be used to assess agreement
between the different techniques used to assess body
composition.
Discussion
Key findings from previous phases of the Newcastle
PTBGS
The growth study showed significantly improved growth
in those receiving the preterm formula although the
growth advantage was greater for boys than girls [30]. At
18 months corrected age, male infants fed preterm for-
mula were 1 kg heavier, 2 cm longer, and had 1 cm
greater head circumference than those fed the term
formula. Increased weight gain primarily reflected an
increase in lean mass as shown by DXA, consistent with
the idea that the preterm formula more closely met
protein-energy needs in rapidly growing preterm maleinfants [62]. However, no RCT group differences were
demonstrated in developmental outcome (BSID) at
18 months despite differences in head growth earlier on.
This may reflect the fact that infants on the term formula
appeared to up-regulate their intake volumes so caloric in-
take was similar between the groups [63]. Differences in
growth are likely then to primarily reflect increases in pro-
tein intake (because the protein: energy ratio was also dif-
ferent between the two formulae). In addition, the greatest
differences in nutrient accretion occurred between dis-
charge and term, with only relatively small differences in
growth thereafter. This suggests that the timing of dietary
intervention may be critical. In term populations in-
creased weight gain in the first few months i.e. in the same
time window as preterm infants post-discharge, is asso-
ciated with later risk of obesity [8].
The protein study did not show any significant diffe-
rences in growth or body composition between isocalo-
ric formula with differing protein concentrations of
2.7 g, 3 g or 3.3 g/100 Kcal. Infants were recruited at
~34 weeks corrected gestation, and continued on the
trial formula until 12 weeks post term [31]. There was a
non-significant trend in boys to increased growth
(higher weight, length and OFC gain) pre-discharge on
the higher protein intakes, but there were no group dif-
ferences at 12 weeks post-term in auxology or body
composition. Protein intakes were closely paralleled by
changes in serum urea nitrogen and these differed be-
tween the groups. The trial may have been relatively
under-powered to show effects of higher protein intake
pre-discharge especially as the protein densities only dif-
fered by 10-20%. Post-discharge there appear to be no
advantage to protein densities higher than 2.7 g/100 kcal.
Data on the relationship between early nutrient in-
takes, growth patterns and subsequent measures of
obesity, insulin sensitivity, cognition and bone mineral
density are being further analysed [64]. Blood and saliva
samples collected at adolescent visits were analysed for
epigenetic correlates of early growth patterns. Change in
weight standard deviation score between term and
12 weeks post-term was used to determine patterns of
catch up growth post-discharge. Exploratory analyses
using microarrays identified differentially expressed
genes in whole blood from children who had either “slow”
(n = 10) or “rapid” (n = 10) early postnatal growth [46,48].
Methylation analyses in 121 samples from the Newcastle
PTBGS identified several potential candidate genes, one of
which (TACSTD2) was analysed in relation to adolescent
body composition. TACSTD2 expression was inversely
correlated with DNA methylation, and both measures
were associated with fat mass (FM) [46]. However, the lack
of an association between a methylation proxy single nu-
cleotide polymorphism and FM suggested that reverse
causation or confounding might explain the association.
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in the PTBGS children with slow or rapid weight gain
was used to generate a panel of differentially expressed
genes for DNA methylation analysis undertaken in a co-
hort of term children with samples collected as part of the
ALSPAC cohort [47]. Of the 29 differentially expressed
genes, there were associations between methylation and at
least one index of body composition (BMI, FM, lean mass,
height) in around one third of them in the comparator
cohort. However, in only one of the 9/29 genes did the
association remain after correction for multiple testing.
This was an association between the ALPL gene, en-
coding the enzyme alkaline phosphatase, and height,
a relationship that has biological plausibility.
The current phase of this study will provide a unique
insight into the metabolism of teenagers born preterm. It
will allow direct correlation of clinical and research mea-
sures of body composition with each other, and with insu-
lin sensitivity, which may be important for future health. It
will allow comparison of directly measured physical acti-
vity and muscle recovery capacity in the cohort as well as
measures of diet. It will also provide an invaluable oppor-
tunity to further examine whether associations between a
variety of early growth and nutritional exposures and later
phenotype, may be modulated by epigenetic mechanisms.
The Newcastle PTBGS is a unique resource in indivi-
duals at high risk of the metabolic syndrome who may
have experienced a range of adverse exposures in pre- and
postnatal life. Detailed phenotypic measures can be corre-
lated with early life nutritional and growth exposures,
and the relationship adjusted for contemporary lifestyle
factors. Precise measures of early growth, appetite,
blood-based biomarkers, and nutrient intake, and the
randomised nature of the interventions along with care-
ful tracking over time mean the Newcastle PTBGS will
provide unique insights into lifecourse epidemiology.
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